angiotensin ii has been researched along with trinitrobenzenesulfonic acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Dong, Y; Wang, XP; Wu, K; Wu, L; Zhang, R | 1 |
Lv, B; Meng, L; Shen, M; Wang, M; Zhang, B | 1 |
2 other study(ies) available for angiotensin ii and trinitrobenzenesulfonic acid
Article | Year |
---|---|
Angiotensin II mediates acinar cell apoptosis during the development of rat pancreatic fibrosis by AT1R.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Disease Models, Animal; Fibrosis; Gene Expression Regulation; In Situ Nick-End Labeling; Losartan; Male; Pancreas; Pancreatic Ducts; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; Trinitrobenzenesulfonic Acid | 2004 |
Mica Can Alleviate TNBS-Induced Colitis in Mice by Reducing Angiotensin II and IL-17A and Increasing Angiotensin-Converting Enzyme 2, Angiotensin 1-7, and IL-10.
Topics: Aluminum Silicates; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Colitis; Eating; Enzyme-Linked Immunosorbent Assay; Interleukin-10; Interleukin-17; Male; Mice; Peptide Fragments; Trinitrobenzenesulfonic Acid | 2020 |